<SEC-DOCUMENT>0001558370-24-009206-index.html : 20240614 <SEC-HEADER>0001558370-24-009206.hdr.sgml : 20240614 <ACCEPTANCE-DATETIME>20240614163121 ACCESSION NUMBER: 0001558370-24-009206 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAPRICOR THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001133869 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-280229 FILM NUMBER: 241045368 BUSINESS ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 BUSINESS PHONE: (310) 358-3200 MAIL ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 FORMER COMPANY: FORMER CONFORMED NAME: Nile Therapeutics, Inc. DATE OF NAME CHANGE: 20070920 FORMER COMPANY: FORMER CONFORMED NAME: SMI PRODUCTS INC DATE OF NAME CHANGE: 20010206 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>tmb-20240308xs3.htm <DESCRIPTION>S-3 <TEXT> Document 1 - file: tmb-20240308xs3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tmb-20240308xex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: tmb-20240308xex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tmb-20240308xex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: tmb-20240308xex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>tmb-20240308xexfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: tmb-20240308xexfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tmb-20240308xex5d1002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tmb-20240308xex5d1002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tmb-20240308xs3001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tmb-20240308xs3001.jpg
</DOCUMENT> </SEC-DOCUMENT>